iDtheinvestordatabase
Home / Directory / Martlet Capital
Active: new deal Jun 2026 Verified 4 Nov 2026

Martlet Capital

Cambridge-based early-stage investor, launched in 2011 and now owned and portfolio-managed by EMV Capital, that backs pre-seed and seed B2B deep tech and life science companies, mainly in the Cambridge cluster. It co-invests alongside angels, seed funds and VCs.

Type
VC firm
Location
Cambridge, United Kingdom
Stages
Pre-seed, Seed
Backs
Biotech and pharma, Deep tech, Hardware
Sectors
Healthtech and life sciences, Biotech, AI, Deep tech, B2B, Semiconductors
Fund size / AUM
75+ investments, 9 exits (own site)
Portfolio mix
Biotech and pharma 28%; Deep tech 24%; Hardware 21%; Medtech and digital health 14%; B2B software 7%; Consumer products 3%; Climate and energy 3% (n=29)

Contacts on file

For Martlet Capital, the paid file holds: 4 named decision-makers with roles; firm contact email (domain checked); check size; how to pitch (the route the firm publishes); LinkedIn page.

Get UK Complete, $149 Free sample

One-time payment. No subscription. No account.

Notable investments

AbcamFrontier DevelopmentsAudio AnalyticParagrafNu Quantum

Sources

Last checked 4 Nov 2026. Is something wrong? Tell us.

Appears in 34 lists